Corvus Pharmaceuticals, Inc.
CRVS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001626971
No open-market purchases or sales by Corvus Pharmaceuticals, Inc. insiders were filed in the last 90 days; 173 institutions reported holding it in 13F filings for Q2 2026, worth $1.06B in total; no superinvestor holds it.
13F holders, Q1 2024
Institutional positions in Corvus Pharmaceuticals, Inc. as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 47
- −1 vs. Q4 2023
- Shares held
- 17.9M
- −1.28M (−6.7%) vs. Q4 2023
- Total value
- $31.9M
- −$1.90M (−5.6%) vs. Q4 2023
- New holders
- 7
- 11 more added
- Sold out
- 8
- 13 more reduced
Compare with Q4 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CRVS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 173 | $1.06B |
| Q1 2026 | 164 | $1.02B |
| Q4 2025 | 124 | $359.4M |
| Q3 2025 | 103 | $312.7M |
| Q2 2025 | 92 | $167.1M |
| Q1 2025 | 88 | $115.4M |
| Q4 2024 | 86 | $202.0M |
| Q3 2024 | 62 | $158.5M |
| Q2 2024 | 47 | $50.2M |
| Q1 2024 | 47 | $31.9M |
| Q4 2023 | 48 | $33.8M |
| Q3 2023 | 52 | $28.0M |
| Q2 2023 | 52 | $44.6M |
| Q1 2023 | 37 | $18.9M |
| Q4 2022 | 42 | $18.2M |
| Q3 2022 | 48 | $18.1M |
| Q2 2022 | 47 | $25.4M |
| Q1 2022 | 57 | $44.9M |
| Q4 2021 | 62 | $66.7M |
| Q3 2021 | 61 | $136.4M |
| Q2 2021 | 50 | $63.2M |
| Q1 2021 | 49 | $62.8M |
Institutions, Q1 2024
Shares, value and share of portfolio for each institution holding Corvus Pharmaceuticals, Inc.; share changes are against Q4 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Barclays PLC | 1 | $2 | 0.00% | 00.0% | Unchanged |
| FMR LLC | 17 | $30 | 0.00% | +17 | New |
| Parallel Advisors, LLC | 20 | $36 | 0.00% | 00.0% | Unchanged |
| IFP Advisors, Inc | 24 | $43 | 0.00% | 00.0% | Unchanged |
| ICA Group Wealth Management, LLC | 165 | $294 | 0.00% | +165 | New |
| Wells Fargo & Company | 265 | $472 | 0.00% | +5+1.9% | Added |
| Rhumbline Advisers | 791 | $1.41K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 1,200 | $2.14K | 0.00% | 00.0% | Unchanged |
| Qube Research & Technologies Ltd | 2,378 | $4.23K | 0.00% | +2,378 | New |
| Northwest Capital Management Inc | 3,397 | $6.05K | 0.00% | 00.0% | Unchanged |
| Group One Trading, L.P. | 4,604 | $8.20K | 0.00% | −32,060−87.4% | Reduced |
| UBS Group AG | 4,679 | $8.33K | 0.00% | −2,021−30.2% | Reduced |
| Rothschild Investment LLC | 7,000 | $12.5K | 0.00% | +7,000 | New |
| Simplex Trading, LLC | 9,346 | $16.0K | 0.00% | −40,285−81.2% | Reduced |
| Masso Torrence Wealth Management Inc. | 10,000 | $17.8K | 0.01% | 00.0% | Unchanged |
| Fortem Financial Group, LLC | 11,000 | $19.6K | 0.01% | +11,000 | New |
| Whittier Trust Co of Nevada Inc | 11,200 | $19.8K | 0.00% | 00.0% | Unchanged |
| Gillespie Robinson & Grimm Inc | 11,480 | $20.4K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 11,511 | $20.5K | 0.00% | +3,008+35.4% | Added |
| Dimensional Fund Advisors LP | 11,924 | $21.2K | 0.00% | 00.0% | Unchanged |
| Virtu Financial LLC | 12,570 | $22.0K | 0.00% | +12,570 | New |
| Charles Schwab Investment Management Inc | 15,668 | $27.9K | 0.00% | 00.0% | Unchanged |
| Resources Investment Advisors, LLC. | 17,950 | $32.0K | 0.00% | +5,550+44.8% | Added |
| American Century Companies Inc | 18,248 | $32.5K | 0.00% | −214−1.2% | Reduced |
| Commerce Bank | 20,000 | $35.6K | 0.00% | 00.0% | Unchanged |
| Quinn Opportunity Partners LLC | 22,327 | $39.7K | 0.00% | +22,327 | New |
| Millennium Management LLC | 23,281 | $41.4K | 0.00% | −17,554−43.0% | Reduced |
| Hikari Power Ltd | 49,959 | $89.0K | 0.01% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 52,824 | $94.0K | 0.00% | +52,145+7,679.7% | Added |
| Jackson Square Capital, LLC | 63,773 | $113.5K | 0.03% | 00.0% | Unchanged |
| Northern Trust Corp | 64,949 | $115.6K | 0.00% | −68−0.1% | Reduced |
| Connor, Clark & Lunn Investment Management Ltd. | 88,008 | $156.7K | 0.00% | +16,800+23.6% | Added |
| Two Sigma Investments, LP | 102,449 | $182.4K | 0.00% | −78,255−43.3% | Reduced |
| Susquehanna International Group, LLP | 105,026 | $186.9K | 0.00% | −115,270−52.3% | Reduced |
| State Street Corp | 120,303 | $214.1K | 0.00% | −18,100−13.1% | Reduced |
| Two Sigma Advisers, LP | 185,100 | $329.5K | 0.00% | −50,500−21.4% | Reduced |
| Bridgeway Capital Management, LLC | 224,300 | $399.3K | 0.01% | +75,000+50.2% | Added |
| Morgan Stanley | 275,361 | $490.1K | 0.00% | +15,706+6.0% | Added |
| BVF Inc | 361,406 | $643.3K | 0.02% | −1,009,541−73.6% | Reduced |
| Geode Capital Management, LLC | 371,763 | $661.9K | 0.00% | +11,383+3.2% | Added |
| Towerview LLC | 382,500 | $680.9K | 0.45% | −54,373−12.4% | Reduced |
| BlackRock Inc. | 522,978 | $930.9K | 0.00% | +2,427+0.5% | Added |
| Renaissance Technologies LLC | 637,032 | $1.13M | 0.00% | +49,600+8.4% | Added |
| Vanguard Group Inc | 1,493,357 | $2.66M | 0.00% | +142,724+10.6% | Added |
| Samlyn Capital, LLC | 2,348,363 | $4.18M | 0.07% | −147,896−5.9% | Reduced |
| Adams Street Partners LLC | 3,275,616 | $5.83M | 2.32% | 00.0% | Unchanged |
| OrbiMed Advisors LLC | 6,943,654 | $12.4M | 0.24% | 00.0% | Unchanged |
| MYDA Advisors LLC | 0 | $0 | 0.00% | −71,011−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −23,415−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −23,095−100.0% | Sold out |
| Bank of New York Mellon Corp | 0 | $0 | 0.00% | −21,219−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −7,654−100.0% | Sold out |
| Natixis | 0 | $0 | 0.00% | −800−100.0% | Sold out |
| Bank of America Corp | 0 | $0 | 0.00% | −22−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −122−100.0% | Sold out |